Subscribe

ACR News

The American College of Rheumatology has issued a position statement on pharmacovigilance, underlining its support for continued monitoring of new drugs and their side effects after they have been approved by the US Food and Drug Administration, which is important in biosimilar development.

San Diego, CA—At the 2017 American College of Rheumatology (ACR) Annual Meeting, Angus Worthing, MD, Arthritis and Rheumatism Associates, Washington, DC, and Chair, ACR Government Affairs Committee, provided a legislative and regulatory update. Discussion topics included ACR contributions on policy development and change, as well as regulatory initiatives currently before Congress and how they may impact rheumatology practices in the future.


Results 1 - 2 of 2
  • American Health and Drug Benefits
  • Lynx CME
  • Value Based Care in Rheumatology
  • Oncology Practice Management
  • Urology Practice Management

Search